Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.

@article{Brada1995ImprovingTA,
  title={Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.},
  author={Michael Brada and George Thomas and Sean Elyan and Nicholas James and Fred Hines and S. C. Ashley and Henry Marsh and Beverly A Bell and Sally Patricia Stenning},
  journal={British Journal of Cancer},
  year={1995},
  volume={71},
  pages={1330 - 1334}
}
Radiotherapy, although clearly beneficial in patients with high-grade glioma, is largely palliative, and a protracted course of treatment may not be the most appropriate approach in the context of limited survival. We therefore assessed the feasibility, toxicity and survival results of a short accelerated radiotherapy regimen given twice daily over a period of 3 weeks. A total of 116 patients with high-grade glioma were treated with radiotherapy in a prospective study using an accelerated… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 22 references

A randomized trial of accelerated hyperfractionated radiation therapy and bis-chlorethyl nitrosourea for malignant glioma

  • Wj Curran, Scott Cb, +6 authors Nelson Df
  • Cancer
  • 1992
Highly Influential
3 Excerpts

Long-term follow-up of National Cancer Institute phase I/II study of glioblastoma multiforme treated with iododeoxyuiidine and hyperfractionated irradiation

  • Te Goffman, Dachowski Ij, +6 authors Glastein E
  • J. Cln. Oncol
  • 1992

Prognostic factors for high-grade malignant glioma: development of a prognostic index

  • Mrc Brain, Tumour, Party
  • J. Neuro-Oncol
  • 1990

Similar Papers

Loading similar papers…